JMKX-003801

N/A

Report date: 2025/02/26 15:15:34
NME

Base Information

Drug NameJMKX-003801
Drug Alias NameJMKX-003801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsUrinary Tract InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangxi Jemincare Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hangyu Pharmaceutical Co LtdJiangxi Jemincare Group Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsGram-Negative Bacterial Infections
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A